ImageneBio (IMA) Net Margin (2020 - 2024)
Historic Net Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 176.6%.
- ImageneBio's Net Margin rose 12869400.0% to 176.6% in Q3 2024 from the same period last year, while for Dec 2024 it was 1529.57%, marking a year-over-year decrease of 7837100.0%. This contributed to the annual value of 744.17% for FY2023, which is 3037000.0% down from last year.
- As of Q3 2024, ImageneBio's Net Margin stood at 176.6%, which was up 12869400.0% from 2981.94% recorded in Q4 2023.
- ImageneBio's 5-year Net Margin high stood at 13.83% for Q4 2021, and its period low was 40081.54% during Q4 2020.
- In the last 5 years, ImageneBio's Net Margin had a median value of 279.79% in 2021 and averaged 3167.46%.
- As far as peak fluctuations go, ImageneBio's Net Margin soared by 400953700bps in 2021, and later plummeted by -50191300bps in 2022.
- Over the past 5 years, ImageneBio's Net Margin (Quarter) stood at 40081.54% in 2020, then soared by 100bps to 13.83% in 2021, then tumbled by -1970bps to 258.66% in 2022, then tumbled by -1053bps to 2981.94% in 2023, then soared by 94bps to 176.6% in 2024.
- Its last three reported values are 176.6% in Q3 2024, 2981.94% for Q4 2023, and 1463.54% during Q3 2023.